Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 25:11:1056.
doi: 10.3389/fneur.2020.01056. eCollection 2020.

Nuclear Transport Deficits in Tau-Related Neurodegenerative Diseases

Affiliations
Review

Nuclear Transport Deficits in Tau-Related Neurodegenerative Diseases

Lisa Diez et al. Front Neurol. .

Abstract

Tau is a cytosolic microtubule binding protein that is highly abundant in the axons of the central nervous system. However, alternative functions of tau also in other cellular compartments are suggested, for example, in the nucleus, where interactions of tau with specific nuclear entities such as DNA, the nucleolus, and the nuclear envelope have been reported. We would like to review the current knowledge about tau-nucleus interactions and lay out possible neurotoxic mechanisms that are based on the (pathological) interactions of tau with the nucleus.

Keywords: Alzheimer's disease; neurodegenerative diseases; nuclear pore complex; nucleocytoplasmic transport; tau protein.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Nuclear envelope distortion and cytoplasmic mislocalization of Nup98 in neurofibrillary tangles (NFTs) of Alzheimer's disease (AD) brain. Human AD (Braak V) and age-matched control brain sections were immunolabeled for phospho-tau (magenta; p-tau mix of anti-phospho-tau antibodies, pS199, pT205, pS262, pT231, and pS409), Nup98 (green), and Dapi (blue). In AD cortex, NFTs filled with phospho-tau show a crinkled/distorted nuclear envelope (white arrows) and Nup98 accumulation in the cytosol. In control nuclei, Nup98 is localized evenly to the nuclear membrane.
Figure 2
Figure 2
Schematic illustration of potential tau–nucleus interactions leading to nucleocytoplasmic transport (NCT) impairment in tau-related neurodegeneration. Under physiological conditions, cytosolic soluble tau is mainly localized to the neuronal axon to stabilize the microtubules. In stress conditions and in the context of neurodegenerative diseases like Alzheimer's disease and tauopathies, tau mislocalizes from the axon into the somatodendritic compartment where it gets in close proximity to the nucleus. Acute stress, for example, via heat shock, transiently increases the amount of intranuclear tau, either by active transport of tau through the nuclear pore complexes (NPC) or other unknown import mechanisms or by the enhanced expression and/or local translation of nuclear tau transcripts. Nuclear tau binds and stabilizes DNA during the time of insult, undertaking a DNA-protective role. Under persistent stress—as in the context of neurodegenerative diseases—the amount of hyperphosphorylated tau in the soma increases further and leads to different possible scenarios of tau-induced NCT disruption, which are accompanied with nuclear envelope abnormalities (e.g., invaginations) and result in neurotoxicity: (1) soluble and/or aggregated tau binds and thereby clogs the nuclear pore, resulting in cargo transport inhibition; (2) tau interacts with specific Nups of the NPC, leading to NPC disassembly and sequestration of Nups from the NPC into the cytosol, resulting in nuclear pore leakiness and co-aggregation of cytoplasmic Nups with tau; (3) somatodendritic tau interacts with Nups that under physiological conditions would associate with transcription factors to regulate gene expression. These interactions “distract” Nups and thereby indirectly affect gene expression.

References

    1. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW. A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA. (1975) 72:1858–62. 10.1073/pnas.72.5.1858 - DOI - PMC - PubMed
    1. Binder LI, Frankfurter A, Rebhun LI. The distribution of tau in the mammalian central nervous central nervous. J Cell Biol. (1985) 101:1371–8. 10.1083/jcb.101.4.1371 - DOI - PMC - PubMed
    1. Black MM, Slaughter T, Moshiach S, Obrocka M, Fischer I. Tau is enriched on dynamic microtubules in the distal region of growing axons. J Neurosci. (1996) 16:3601–19. 10.1523/JNEUROSCI.16-11-03601.1996 - DOI - PMC - PubMed
    1. Ballatore C, Lee VMY, Trojanowski JQ. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci. (2007) 8:663–72. 10.1038/nrn2194 - DOI - PubMed
    1. Goedert M, Spillantini MG. Pathogenesis of the tauopathies. J Mol Neurosci. (2011) 45:425–31. 10.1007/s12031-011-9593-4 - DOI - PubMed

LinkOut - more resources